Anti-Hu CD107a Pacific Blue™

*Majer F, Vlaskova H, Krol L, Kalina T, Kubanek M, Stolnaya L, Dvorakova L, Elleder M, Sikora J: Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency. Gene. 2012 May 1;498 (2) :183-95. (FC), URL: https://pubmed.ncbi.nlm.nih.gov/22365987/, *Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan PL, Lam KT, Peiris JS, Lau YL: Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol. 2010 May;84 (9) :4148-57. (FC), URL: http://www.ncbi.nlm.nih.gov/pubmed/20164232 , *Yu CI, Gallegos M, Marches F, Zurawski G, Ramilo O, García-Sastre A, Banchereau J, Palucka AK: Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood. 2008 Nov 1;112 (9) :3671-8. (FC), URL: https://www.ncbi.nlm.nih.gov/pubmed/18713944, *Tomescu C, Chehimi J, Maino VC, Montaner LJ: NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. J Immunol. 2007 Aug 15;179 (4) :2097-104. (FC), URL: https://www.ncbi.nlm.nih.gov/pubmed/17675468, *Carlsten M, Björkström NK, Norell H, Bryceson Y, van Hall T, Baumann BC, Hanson M, Schedvins K, Kiessling R, Ljunggren HG, Malmberg KJ: DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 2007 Feb 1;67 (3) :1317-25. (FC), URL: https://www.ncbi.nlm.nih.gov/pubmed/17283169, *Marcenaro S, Gallo F, Martini S, Santoro A, Griffiths GM, Aricó M, Moretta L, Pende D: Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL) : defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006 Oct 1;108 (7) :2316-23. (FC), URL: https://www.ncbi.nlm.nih.gov/pubmed/16778144, *Deetz CO, Hebbeler AM, Propp NA, Cairo C, Tikhonov I, Pauza CD: Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-Like receptor 2 agonist Pam3Cys. Infect Immun. 2006 Aug;74 (8) :4505-11. (FC), URL: https://www.ncbi.nlm.nih.gov/pubmed/16861636, *Furuta K, Ikeda M, Nakayama Y, Nakamura K, Tanaka M, Hamasaki N, Himeno M, Hamilton SR, August JT: Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases. Am J Pathol. 2001 Aug;159 (2) :449-55. (IHC-P), URL: https://www.ncbi.nlm.nih.gov/pubmed/11485903, *Mane SM, Marzella L, Bainton DF, Holt VK, Cha Y, Hildreth JE, August JT: Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys. 1989 Jan;268 (1) :360-78. (IHC-P, IHC-F), URL: https://pubmed.ncbi.nlm.nih.gov/2912382/

*Grützkau A, Smorodchenko A, Lippert U, Kirchhof L, Artuc M, Henz BM: LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A. 2004 Sep;61 (1) :62-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/15351990?ordin, *Barrachina M, Maes T, Buesa C, Ferrer I: Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease. Neuropathol Appl Neurobiol. 2006 Oct;32 (5) :505-16., URL: https://www.ncbi.nlm.nih.gov/pubmed/16972884?ordin, *Sarafian VS, Marinova TT: Lysosomal membrane-associated glycoproteins are differentially expressed in acute and chronic human thymic involution. Acta Biol Hung. 2006 Sep;57 (3) :315-22., URL: https://www.ncbi.nlm.nih.gov/pubmed/17048695?ordin, *Eskelinen EL: Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med. 2006 Oct-Dec;27 (5-6) :495-502., URL: https://www.ncbi.nlm.nih.gov/pubmed/16973206?ordin, *Hunyh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S: LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 2007 Jan 24;26 (2) :313-24., URL: https://www.ncbi.nlm.nih.gov/pubmed/17245426?ordin